Comparative physicochemical and biological characterization of the similar imiglucerase product Glurazyme® and the originator product Cerezyme®

A biosimilar considered as a biomolecule medicinal product that is comparable to a reference medicinal product in terms of the structural, functional, biological, and clinical attributes. Glurazyme® was developed as a biosimilar to Cerezyme® (imiglucerase) and was approved in CIS countries (Russian...

Full description

Saved in:
Bibliographic Details
Main Authors: Maksim Smolov, Serge Taran, Ivan Lyagoskin, Maria Neronova, Maksim Degterev, Rakhim Shukurov
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Journal of Pharmaceutical and Biomedical Analysis Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2949771X23000245
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items